Results 211 to 220 of about 49,575 (291)

EGFR-TKIs with or without stereotactic body radiotherapy to primary lesion in the advanced EGFR-mutated non-small cell lung cancer. [PDF]

J Thorac Dis
Yuan Z, Tao D, Yang D, Jiang Y, Munai E, Zeng S, Zhou W, Wu Y.   +7 more
europepmc   +1 more source

Influence of inter-fractional respiratory motion changes on dose delivery accuracy in dynamic conformal arc lung stereotactic body radiotherapy: A phantom study. [PDF]

PLoS One
Bae BK, Kim SJ, Kim JC.
europepmc   +1 more source

A multi-institutional dummy run on segmentation variability and plan quality of stereotactic body radiotherapy for oligometastatic disease. [PDF]

Phys Imaging Radiat Oncol
Hirashima H, Matsuo Y, Ishikura S, Nakamura M, Nishibuchi I, Kawahara D, Shimada Y, Nakahara Y, Nishio T, Shikama N, Watanabe SI, Okamoto I, Ishiba T, Hara F, Shien T, Mizowaki T.   +15 more
europepmc   +1 more source

Stereotactic body radiotherapy: a new non-invasive way to conduct pulmonary artery denervation. [PDF]

Front Med (Lausanne)
Liao M, Yao T, Xie Y, Kutty S, Liu J, Peng W, Huang T, Chen H, Fan H, Xiao Z, Liu Q, Xiao Y.   +11 more
europepmc   +1 more source

Supplementary Figures S1-S22 from Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study

Alice Markussen, Julia S. Johansen, Finn Ole Larsen, Susann Theile, Jane Preuss Hasselby, Gro Linno Willemoe, Torben Lorentzen, Kasper Madsen, Estrid Høgdall, Tim Svenstrup Poulsen, Eva E. Wilken, Poul Geertsen, C.F. Behrens, Inge Marie Svane, Dorte Nielsen, Inna M. Chen   +15 more
openalex   +1 more source

Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial. [PDF]

Nat Commun
Tang J, Yang Y, Liu D, Wang B, Lin Z, Wu Z, Zhang J, Zhang D, Liu Y, Ge M, Chen L, Wu G, Zhang T, Xue J.   +13 more
europepmc   +1 more source

Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy [PDF]

Fang Fang, Zhen Jia, Hongliang Xie, Yangsen Cao, Xiaofei Zhu, Xiao Yu Yang, Xueling Guo, Huojun Zhang   +7 more
openalex   +1 more source

Efficacy and safety of stereotactic body radiotherapy for hepatocellular carcinoma with tumor thrombus in right atrium: a two-center retrospective review. [PDF]

Radiat Oncol
Shui Y, Yang J, Zhao X, Yang Y, Yu C, Dai D, Chen L, Chen H, Chen D, Li X, Liu L, Tian Q, Guo Y, Zhang H, Wei Q.   +14 more
europepmc   +1 more source

Comparison of liver stereotactic body radiotherapy plans based on free breathing and averaged CTs after trans-arterial chemoembolization using lipiodol. [PDF]

J Appl Clin Med Phys
Kang SK, Yoon JW, Kim MY, Park S, Cheong KH, Koo T, Han TJ.   +6 more
europepmc   +1 more source

Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles. [PDF]

Front Pharmacol
Maiorano MFP, Maiorano BA.
europepmc   +1 more source